Biomedical Engineering Reference
In-Depth Information
854. Deguchi Y, Nozawa K, Yamada S, Yokoyama Y, Kimura R. 1997. Quantitative evaluation
of brain distribution and blood-brain barrier efflux transport of probenecid in rats by
microdialysis: possible involvement of the monocarboxylic acid transport system.
J Pharmacol Exp Ther 280: 551-560.
855. Deguchi Y, Yokoyama Y, Sakamoto T, Hayashi H, Naito T, Yamada S, Kimura R. 2000.
Brain distribution of 6-mercaptopurine is regulated by the efflux transport system in the
blood-brain barrier. Life Sci 66: 649-662.
856. Bliss TM, Ip M, Cheng E, Minami M, Pellerin L, Magistretti P, Sapolsky RM.
2004. Dual-gene, dual-cell type therapy against an excitotoxic insult by bolstering
neuroenergetics. J Neurosci 24: 6202-6208.
857. Sapolsky RM. 2003. Neuroprotective gene therapy against acute neurological insults.
Nat Rev Neurosci 4: 61-69.
858. Osato DH, Huang CC, Kawamoto M, Johns SJ, Stryke D, Wang J, Ferrin TE, Herskowitz
I, Giacomini KM. 2003. Functional characterization in yeast of genetic variants in the
human equilibrative nucleoside transporter, ENT1. Pharmacogenetics 13: 297-301.
859. Owen RP, Lagpacan LL, Taylor TR, de la Cruz M, Huang CC, Kawamoto M, Johns SJ,
Stryke D, Ferrin TE, Giacomini KM. 2006. Functional characterization and haplotype
analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2.
Drug Metab Dispos 34: 12-15.
860. Owen RP, Gray JH, Taylor TR, Carlson EJ, Huang CC, Kawamoto M, Johns SJ,
Stryke D, Ferrin TE, Giacomini KM. 2005. Genetic analysis and functional character-
ization of polymorphisms in the human concentrative nucleoside transporter, CNT2.
Pharmacogenet Genom 15: 83-90.
861. Gray JH, Mangravite LM, Owen RP, Urban TJ, Chan W, Carlson EJ, Huang CC,
Kawamoto M, Johns SJ, Stryke D, Ferrin TE, Giacomini KM. 2004. Functional
and genetic diversity in the concentrative nucleoside transporter, CNT1, in human
populations. Mol Pharmacol 65: 512-519.
862. Griffiths M, Yao SY, Abidi F, Phillips SE, Cass CE, Young JD, Baldwin SA. 1997.
Molecular cloning and characterization of a nitrobenzylthioinosine- insensitive (
ei
)
equilibrative
nucleoside
transporter
from
human
placenta.
Biochem
J
328:
739-
743.
863. Ward JL, Sherali A, Mo ZP, Tse CM. 2000. Kinetic and pharmacological properties of
cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed
in nucleoside transporter-deficient PK15 cells. J Biol Chem 275: 8375-8381.
864. Vickers MF, Kumar R, Visser F, Zhang J, Charania J, Raborn RT, Baldwin SA, Young JD,
Cass CE. 2002. Comparison of the interaction of uridine, cytidine, and other pyrimidine
nucleoside analogues with recombinant human equilibrative nucleoside transporter 2
(hENT2) produced in
Saccharomyces cerevisiae
. Biochem Cell Biol 80: 639-644.
865. Lum PY, Ngo LY, Baggen AH, Unadkat JD. 2000. Human intestinal es nucleoside
transporter:
molecular
characterization
and
nucleoside
inhibitory
profiles.
Cancer
Chemother Pharmacol 45: 273-278.
866. Yao SY, Ng AM, Vickers MF, Sundaram M, Cass CE, Baldwin SA, Young JD. 2002.
Functional and molecular characterization of nucleobase transport by recombinant human
and rat equilibrative nucleoside transporters 1 and 2. Chimeric constructs reveal a role for
the ENT2 helix 5-6 region in nucleobase translocation. J Biol Chem 277: 24938-24948.
Search WWH ::
Custom Search